The global stereotactic surgery devices market size is expected to reach USD 37.27 Billion in 2032 and register a steady revenue CAGR of 3.9% during the forecast period, according to the latest analysis by Emergen Research. The increasing prevalence of chronic diseases is a key factor driving market revenue growth. Every year, 41 million individuals globally die from chronic illnesses such as diabetes, cancer, chronic lung disorders, and Cardiovascular Diseases (CVDs). Chronic disease prevention and funding are crucial. Stereotactic radiosurgery is a very precise type of therapeutic radiation that can be used to treat brain and spine disorders such as cancer, epilepsy, trigeminal neuralgia, and arteriovenous malformations. Stereotactic radiosurgery does not require an incision or opening; instead, X-ray beams are precisely aimed at aberrant tissues through the skin from numerous directions. Radiosurgery operates similarly to other modalities of therapeutic radiology. The X-ray beams damage or destroy the deoxyribonucleic acid (DNA) of cells in aberrant places, preventing them from reproducing and growing. The aberrant tissue becomes inert and eventually diminishes with proper therapy. A mechanized arm that travels around the patient during therapy can be used to treat lesions in the spine or other areas.
The top competitors in the market, their goals for business expansion, and their development strategies are all closely examined in the Stereotactic Surgery Devices Market report. The archive encourages businesspeople to look up information about potential customers and places where they might be located. The review, which only highlights the greatest sellers, can help entrepreneurs find potential customers and discover more about their local market.
Competitive Terrain:
The global Stereotactic Surgery Devices industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.
Leading Market Players Profiled in the Report:
Elekta AB, Accuracy Inc., Ion Beam Applications SA, Mevion Medical Systems, Micromar, Inomed, Alliance Oncology, Medical AG, Monteris Medical, and Varian Medical Systems Inc
To access the full coverage of the global Stereotactic Surgery Devices market report, visit @ https://www.emergenresearch.com/industry-report/stereotactic-surgery-devices-market
Some Key Highlights From the Report
- On 9 January 2023, GE HealthCare announced that it has agreed to purchase IMACTIS, a pioneer in the rapidly expanding field of Computed Tomography (CT) interventional guidance across a wide range of service areas. IMACTIS is a French company founded in 2009 by Stephane Lavallee and Lionel Carrat, who developed CT-Navigation, an ergonomic universal solution that provides stereotactic needle guidance, allowing intuitive pre-planning and continuous control across a wide range of procedures, from diagnosis to treatment.
- The gamma knife segment is expected to account for largest revenue share in the global stereotactic surgery devices market over the forecast period owing to its various benefits. Radiosurgery, also known as stereotactic radiosurgery, using a Gamma Knife is a type of radiation therapy. A gamma knife method, despite its name, does not involve incisions, which is not even a knife. Gamma knife uses incredibly precise gamma ray beams to treat a sick (lesion) or developing (tumor) location. This is most often used in In addition, gamma radiation beams offer a high dose of radiation to a small area without requiring an incision. Radiosurgery destroys cells and prevents their growth and a lesion or tumor will shrink in size over time. Gamma Knife radiosurgery is referred to as surgery since the end result is akin to surgical excision of a lesion.
- The brain tumor treatment segment is expected to register steadily fast revenue growth rate in the global stereotactic surgery devices market over the forecast period. Stereotactic Radiosurgery (SRS) uses a large number of well-focused radiation beams to treat tumors and other disorders in brain, neck, lungs, liver, spine, and other areas of body. Stereotactic radiosurgery of brain and spine is often performed in a single session. Body radiosurgery is used to treat tumors of lung, liver, adrenal gland, and other soft tissues, and treatment typically takes three to five sessions. Gamma knife radiosurgery is a type of radiation therapy used to treat brain tumors, vascular malformations, and other anomalies. Gamma Knife radiosurgery makes use of specialized equipment to accurately focus 200 tiny beams of radiation on a tumor or other target.
- The North America market accounted for largest revenue share in the global stereotactic surgery devices market during the forecast period. This is attributed to increasing activities by key market players in countries in this region. Accuray, a biomedical company based in the U.S., recently announced that Auckland Radiation Oncology (ARO) will be the first in New Zealand to treat patients with CyberKnife System, a robotic radiation therapy device known for delivering treatments with sub-millimeter precision and accuracy in 1 to 5 outpatient sessions. ARO medical care team selected the latest generation CyberKnife S7 System to more efficiently provide Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) to patients, reducing time spent on daily treatments and increasing number of New Zealand cancer patients treated each day.
Key market aspects studied in the report:
Market Scope: The report explains the scope of various commercial possibilities in the global Stereotactic Surgery Devices market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.
Competitive Outlook: The leading companies operating in the Stereotactic Surgery Devices market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.
Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Stereotactic Surgery Devices market.
Market Overview:
The report bifurcates the Stereotactic Surgery Devices market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
Segments Covered in this report are:
- Product Type Offering Outlook (Revenue, USD Billion; 2019–2032)
- Gamma Knife
- Linear Accelerator (LINAC)
- Proton Beam Radiation Therapy
- Cyber Knife
- Application Outlook (Revenue, USD Billion; 2019–2032)
- Brain Tumor Treatment
- Arteriovenous Malformations Treatment
- Parkinson’s Disease Treatment
- Epilepsy Treatment
- Others
- End-Use Outlook (Revenue, USD Billion; 2019–2032)
- Hospitals
- Laboratories
Regional Outlook:
- North America (the U.S., Canada, Mexico)
- Europe (the U.K., Germany, France, Italy)
- Asia Pacific (India, China, Japan, Korea)
- Latin America (Brazil, Argentina, Ecuador, Chile)
- Middle East & Africa (Egypt, Turkey, Saudi Arabia, Iran)
Key reasons to buy the Global Stereotactic Surgery Devices Market report:
- The latest report comprehensively studies the global Stereotactic Surgery Devices market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.
- The report offers an insightful analysis of the regional outlook of the market.
- It offers a detailed account of the end-use applications of the products & services offered by this industry.
- The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.
Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.